Irritable bowel syndrome is a gastrointestinal tract disorder characterized by abdominal pain and altered bowel habits. It hampers the natural movement of intestinal muscle linings to move food along the digestive tract. Depending on the symptoms, the syndrome is distinguished as mild and severe irritable bowel syndrome. These symptoms include cramping, abdominal pain, bloating and gas, mucus in the stool, constipation, and diarrhea. Exact cause of occurrence of irritable bowel syndrome is unknown though, it is associated with increased awareness of bodily functions, and abnormal gastrointestinal tract movements. Diagnosis of irritable bowel syndrome is done by tests such as blood tests, stool tests, endoscopic procedures and external imaging procedures. Patients suffering from irritable bowel syndrome may experience complications namely, deep ulcerations, infections, and malnutrition and bowel obstructions. Treatment of irritable bowel syndrome involves relieving the patient from the symptoms and improving the quality of life.
Ask for Sample Copy of This Research @ https://www.coherentmarketinsights.com/insight/request-sample/506 Market Dynamics The rise in number of gastrointestinal disorders are leading to increasing prevalence of irritable bowel syndrome, for which various companies such as Ironwood Pharmaceuticals, Inc. as well as NGOs conduct mass workshops for educating the people to incorporate healthy food habits as a major precaution towards prevention of IBS. Furthermore, major growth drivers for the irritable bowel syndrome treatment market are expected launches of various pipeline drugs for the treatment during the forecast period and increase in levels of stress associated with changing lifestyle as people suffering from IBS have a colon with sensitivity towards certain foods and stress. According to a survey by Buscopan IBS Relief in 2016, stress was the cause for seven out of ten patients suffering from gastrointestinal pain. The large population of stress and anxiety disorder patients are expected to fuel the growth of the global irritable bowel syndrome treatment market. The global irritable bowel syndrome treatment market was valued at US$ 726.1 million in 2016 and is expected to witness a robust CAGR of 12.9% over the forecast period (2017-2025). Increase in levels of stress and adoption of sedentary lifestyle is expected to increase the prevalence of lifestyle disorders namely irritable bowel syndrome The number of available irritable bowel syndrome drugs has increased over the last few years and new drugs have been approved for the treatment. North America accounts for the largest share in the global irritable bowel syndrome treatment market, followed by Europe and Asia-pacific, respectively. According to an article published in the Brandon Gaille in 2017, on an average, junk food accounts for 28.8% of the total caloric intake of an American. According to Centers for Disease Control and Prevention (CDC) in 2015, it was estimated that 1.3% of U.S. adults i.e. 3 million were reported to being diagnosed with IBD. Consumption of unhealthy food in large quantities raises the bar of probability for IBS acting as a driving factor for the global market growth. Global Key Players Some major players operating in the irritable bowel syndrome treatment market are Abbott Laboratories, Synergy Pharmaceuticals, Inc., Sucampo Pharmaceuticals, Inc., Valeant Pharmaceuticals International, Inc., Ardelyx, Inc., Astellas Pharma Inc., Novartis AG, GlaxoSmithKline plc., and Ironwood Pharmaceuticals, Inc. Detailed Segmentation: Global Irritable Bowel Syndrome Treatment Market, By Drug Type:
Global Irritable Bowel Syndrome Treatment Market, By Medical Condition:
Browse In-Depth Analysis Research Report @ https://www.coherentmarketinsights.com/market-insight/irritable-bowel-syndrome-treatment-market-506 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected]
0 Comments
4/30/2019 Automatic Cell Imaging System Market Exhibits Higher Growth Prospects During 2018-2026Read NowLive cell imaging, or cell imaging is the examination of living cells using time-lapse microscopy (time-lapse photography applied to microscopy). Cell Imaging is used by scientists to get a better understanding of the biological functions of the body in the course of the study of cellular dynamics. The process was established in first half of the 20th century. The first time-lapse microcinematographic films showed the development and fertilization of a sea urchin egg. Various methods of microscopy have since been developed, thereby allowing researchers to experiment on living cells with greater detail and with less effort. A new kind of imaging, which uses quantum dots, has been pioneered as they are found to be more stable.
Get Free Exclusive PDF Sample Copy of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/499 Cell imaging has become an important tool in medical research. Automatic microscopy and image analysis are used to study a variety of different things such as the influence of chemical compounds on cell development. Researchers in this field primarily want to see which compounds capture the cell cycle or the time they take to incubate and at what concentration. Cell cycle is a rigid sequence of phases that a cell undergoes while it is on its dividing phase. If anything goes wrong at some stage during the transition from one phase to other, the cell generally enters cell death that is programmed. Studying these procedures needs intricate image analysis workflows that can be mind-numbing to ascertain. This process is sped up by the use of modular software. Automated cell imaging also find its usage in the drug discovery processes for various diseases, for instance, cancer drugs. As the prevalence of cancer around the world is rising at an alarming rate, the automatic cell imaging system market is likely to gain significant traction during the forecast period. High prevalence of cancer will drive the overall automatic cell imaging system market According to the National Cancer Institute, an estimated 1,685,210 new cases of cancer were diagnosed in the U.S. alone and around 595,690 people died from the disease in 2016. The most common cancers were breast cancer, colon and rectum cancer, kidney and renal pelvis cancer, prostate cancer, non-Hodgkin lymphoma, leukemia, thyroid cancer, lung and bronchus cancer, melanoma of the skin, bladder cancer, pancreatic cancer, and endometrial cancer. The quantity of new cases of cancer was 454.8 per 100,000 women and men per year (statistic based on 2008-2012 cases). Additionally, the number of deaths due to cancer was 171.2 per 100,000 women and men per year (statistic based on 2008-2012 cases). As the occurrence of cancer is rising at an alarming rate, so is the need for automatic cell imaging system. Automatic cell imaging system offers grass root level analysis of the division of cancer cells and hence researchers are using this technique to find a cure to the fatal disease. This is likely to fuel the growth of the overall automatic cell imaging system market. Top Movers of The Market Some of the key players operating in the global automatic cell imaging system market are GE Healthcare Life Sciences, West Medica, Norma Diagnostika GmbH, Bioview, Caliber I.D., Molecular Devices, BioTek Instruments, and PerkinElmer. Automatic Cell Imaging System Market Taxonomy - On the basis of type of product,
On the basis of end user,
Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/automatic-cell-imaging-system-market-499 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] Medical breathable tape, also known as surgical tape is a pressure-sensitive adhesive tape used in first aid and medicine, commonly to hold a bandage onto a wound. Breathable tapes usually have a hypoallergenic adhesive, which is specially designed for firm holding onto skin and can be removed easily without damaging the skin. They are termed breathable as they easily allow air to reach the skin. Latex free medical grade adhesive offers a major advantage with patients suffering from sensitive and fragile skin. The breathable tapes such as Kinesiology Tape are elastic bandages with adhesives made of cotton. Surgical tapes contains zinc oxide which help in preventing infections. 3M tape made of microporous material are widely used post surgeries.
Ask Sample Copy of Research @ https://www.coherentmarketinsights.com/insight/request-sample/488 The common types of medical breathable tapes are:
Request For Customization of Research Report @ https://www.coherentmarketinsights.com/insight/request-customization/488 Alternative wound care products restraining the market growth Although the number of surgeries performed every year is increasing globally owing to increasing incidence of chronic diseases and accidents, impact of alternative wound care and closure products is expected to the restrain the market growth. Use of adhesives and sealants counters the market growth of medical breathable tapes. However, demand for medical breathable tapes is still significant in emerging economies where the penetration of newer wound care products is still lower compared to developed economies such as the U.S., Canada, Germany, France and the U.K. 3M is at the forefront for adhesive innovation with a commitment to enhance patient safety Key players operating in the medical breathable tapes market are 3M, DYNAREX, Medtronic, and Medline Industries. 3M is expected to dominate the global market with the production of innovatory adhesives like Universal Cloth Adhesive Tape to enhance patient safety. Other vendors focusing on strengthening their global presence by introducing inexpensive products include NICHIBAN, BSN Medical, McKesson, Johnson & Johnson Consumer Companies, DUKAL, Smith & Nephew plc. The global medical breathable tapes market is segmented on the basis of product type, end user and geography. Based on the product type, the global medical breathable tapes market is segmented into:
Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/medical-breathable-tapes-market-488 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] Carbon nanotubes (CNTs) are cylindrically shaped structures with diameter of one-billionth of a meter, which is 100 times stronger and just one-sixth as heavy as steel. The high strength and low weight combined with physical flexibility is the most noteworthy property of carbon nanotubes. Carbon nanotubes exhibit higher thermal and electrical conductivity than conventional copper tubes. Carbon nanotubes are increasingly being used as an efficient tool in transporting drug molecules, while it plays a major role in body implants, dental filling, and medical device components. CNTs are functionalized with bioactive peptides, proteins, nucleic acids, and drugs for targeted drug delivery to the cells and organs. Carbon nanotubes assure low toxicity and are not immunogenic, due to which it has potential application in the field of nanomedicine and nanobiotechnology, among others.
Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/469 Increasing healthcare applications to boost market growth According to a study conducted by The University of Cambridge, in 2016, the global CNT production capacity has increased tenfold over the last 5 years due to exponential rise in demand for carbon nanotubes across various industries such as electronics, semiconductors, chemical & polymers, advanced materials, and batteries & capacitors is driving growth of the carbon nanotubes market. Furthermore, increasing incorporation of carbon nanotubes in the healthcare sector for therapies such as cancer, hyperthermia, gene therapy, tissue regeneration, and artificial implants is drastically driving growth of the carbon nanotube market. Its superior mechanical & transport properties are the major factors for growth of the carbon nanotubes market. Financial backing from government bodies to boost market growth in Asia Pacific Europe is expected to hold the largest market share, owing to high incidence of cancer in the region. According to the research published by National Centre of Biotechnology Information in Europe in 2012, 29,300 cancer cases were registered every year and carbon nanotubes proved an effective diagnostics in curing the major types of cancer. Increasing government investments in research and development in the field of nanotechnology integrated with healthcare is driving growth of the carbon nanotubes market. The use of carbon nanotube scaffolds in tissue engineering represent a promising carbon nanotube market Key players operating the carbon nanotubes market include CNano Technology Limited, Hanwha Nanotech Corporation, Kumho Petrochemical Company Ltd. Scaffold designing and fabrication are major areas of biomaterial synthesis, which have increased the demand for carbon nanotubes, in turn boosting market growth. Other prominent participants include Showa Denko, Carbon Solutions, Future Carbon GmbH, and Continental Carbon Nanotechnologies Inc. Advent of multi-wall carbon nanotubes fueling market growth On the basis of product type, the carbon nanotubes market is segmented into:
On the basis of application, the carbon nanotubes market is segmented into:
Browse Complete Research Report @ https://www.coherentmarketinsights.com/ongoing-insight/carbon-nanotubes-market-469 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] 4/22/2019 Medical Non-woven Disposables Market detailed strategies, financials, Competitive landscapingRead NowHealthcare workers are exposed to infected liquid droplets and aerosols that possess the risk of transmitting diseases such as hospital acquired infections (HSIs) and surgical site infections (SSIs). To avoid susceptibility of such contamination, healthcare workers use surgical face masks, gloves, gowns, caps, and shoe covers, which are produced by fabric foaming technology such as woven, non-woven and knitted. Non-woven surgical fabrics have been adopted by most hospitals, as they are disposable in nature. Such materials have been developed due to advancements in technology over the recent past.Non-woven fabric forming technology is less costly than woven and knitted technology. The materials used for non-woven sheets include polypropylene, polyester, polycarbonate, polyethylene, and polystyrene. The filtration process of non-woven fabrics has various advantages over woven and knitted fabrics such as its higher bacterial filtration efficiency, higher air permeability, no yarn slippage, lesser contamination risk , and lower manufacturing cost.
Global Medical Non-woven Disposables Market Taxonomy By product – On the basis of product type, the medical non-woven disposables market is segmented into: Surgical product,Wound dressings,Incontinence product Non-woven disposable products offers opportunities for favorable growth of the medical non-woven disposables market. Over the past decades, demand for polymeric nanofibers has tremendously increased, owing to its very large surface area to volume ratio. This exceptional property is suitable for application in medical textile products such as drug delivery systems, surgical face masks, and wound dressing. Demand for technology offering high absorbent capacity and antimicrobial properties to help reduce chances of cross-contamination, is increasing in the manufacturing of non-woven fabrics. Microencapsulation technology offers immense opportunities to improve properties of medical textile. Suspension of microcapsule is formulated in the development of non-woven textile with prolonged antimicrobial activity. The textile is then impregnated with microcapsules that are pressure-sensitive, which release the active ingredient upon pressure. Request For Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/888 Momentive performance material, in 2011, launched NuWet 550 Hydrophilic silicone finish for non-woven medical disposables, it gives a long-lasting hydrophilic finish to non-woven fabrics such as diapers, surgical wipes. Silicone finish is employed in the medical industry help minimize the migration of water to unwanted areas during surgical processes. Increasing prevalence of hospital acquired infections and improving hygienic habits among people to favor growth of the medical non-woven disposables market Increasing prevalence of hospital acquired infections is one of the major factors driving growth of the medical non-woven disposables market. According to Centers for Disease Control and Prevention, in 2014, around 722,000 people contracted HAIs in acute care hospitals and around 75,000 patients suffering from HAIs died during hospitalization in the U.S. European Centre for Disease Prevention and Control, 2016, reported that from around 87337 patients admitted in the ICU for over two days, around 6995 patients were recorded with at least one HAI. Furthermore, CDC and the Association of State and Territorial Health Officials (ASTHO) have collaborated since July 2010, to ensure funding for basic elements of HAI program infrastructure at the federal, state, and local levels. Growing geriatric population has increased the demand for medical non-woven disposables, in turn, boosting growth of the market. Growing awareness regarding improved hygienic habits among the populace and introduction of new products in the incontinence segment are expected to fuel grow of the medical non-woven disposables market in the near future. High demand for surgical products in developed countries, has fueled growth of the incontinence and surgical product segments, in turn creating immense opportunities for growth of the global medical non-woven disposables market. Major key players operating in the medical non-woven disposables market include Kimberly-Clark Corporation, Medline Industries, Inc., Paul Hartmann AG, Mölnlycke Health Care, Ahlstrom Corporation, Asahi Kasei Corporation, Medtronic, Inc., Svenska Cellulosa, Freudenberg & Co. KG, Aktiebolaget SCA, and Domtar Corporation. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/888 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:[email protected] An excimer laser, or exciplex laser, is an ultraviolet form of laser. Excimer laser devices find application in eye surgery, production of microelectronic equipment, micromachining, and manufacturing of semiconductor based integrated circuits or chips. An excimer laser mainly consists of reactive gases such as fluorine or chlorine coupled with noble gases, including argon, krypton, and/or xenon. Unlike conventional lasers, laser action in an excimer laser arises from repulsive or dissociative ground state as opposed to being in an excited state. This is due to the fact that noble gases such as krypton and xenon are highly inactive and generally do not form chemical compounds. Nevertheless, when they are in an excited state (induced by a high energy electron beam or an electrical discharge), they can form momentarily bound molecules with themselves known as dimmers or with halogens such as fluorine or chlorine, known as complexes. The compound in its excited state can release its excess energy by undergoing stimulated or spontaneous emission, thereby giving rise to a strongly repulsive molecule in its ground state which dissociates into two unbound atoms on the order of picoseconds. This is the basic functioning of an excimer laser device.
Download PDF Brochure of This Business Report @ https://www.coherentmarketinsights.com/insight/request-pdf/462 The key industrial use of the excimer lasers is in microelectronic devices and equipment along with ultraviolet photolithography. Excimer lasers have significantly high power ultraviolet output which makes it very useful for surgeries. This is acting as a driving factor for the growth of the excimer laser devices market. Moreover, excimer lasers also find its application in research laboratory equipment. Most important applications of excimer lasers are photolithography for semiconductor chips, laser ablation, micro-structuring of transparent media, pulsed laser deposition, eye surgery, laser marking, psoriasis treatment and dye-laser pumping. Rising number of surgeries and high application areas of excimer lasers will drive the overall excimer laser devices market The lifespan of an excimer laser is mainly limited by gas contamination, corrosion processes, dust produced by electric discharge, apart from high voltage electronics. These are some of the restraining factors that might affect the market negatively during the forecast period. However, varied application areas of excimer laser devices such as medicine, construction, and semiconductor is likely to encourage the growth of the excimer laser devices market during the forecast period. In 2016, North America held the maximum share of the market. The U.K., Germany, France, and Italy are some of the other countries which have a significant share of the market. The increasing volume of surgical procedures across the globe is likely to drive the overall growth of the digital wound management devices market during the forecast period. Surgeries are conducted to manage various diseases including gastrointestinal diseases, cardiovascular diseases, spinal abnormalities, urological disorders, orthopedic deformities, and brain tumors. The significant growth in the number of surgeries, especially in the European countries will help in the growth of the excimer laser devices market in this region. In the Asia Pacific region, Japan, China, India, and South Korea are the leading market players. In South America region, Brazil and Argentina are likely to boost the excimer laser devices market in this region. Top Key Players Some of the major companies operating in the excimer laser devices market are Alcon, Inc., Coherent, Inc., NIDEK Co. Ltd., Wavelength Opto Electronic (S) Pte Ltd., Laser 2000 GmbH, AMS Technologies AG, Ziemer Opthalmic Systems AG, and Radiant Dyes Laser & Accessories GmbH. Excimer laser devices market Taxonomy On the basis of application,
On the basis of end-user,
Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/excimer-laser-devices-market-462 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] Recombinant vaccines are produced by using recombinant DNA technology or genetic engineering for the prevention of lethal diseases in human beings and animals. Recombinant vaccine is a biological preparation that provides active acquired immunity against a certain disease. Whereas individual being vaccinated produces antibodies against the protein antigen that protect a person from contracting the disease upon attack from the pathogenic microorganism. These vaccines functions on the immune response for diseases and to have preventive measures against diseases caused by various bacteria, and virus. These vaccines are much more advanced and effective as compare to conventional vaccines in the prevention of diseases such as malaria, typhoid, and human papillomavirus (HPV). Furthermore, Europe dominates the animal recombinant vaccines market as compared to other regions due to highly organized livestock and major demand for livestock products in Europe.
Get Free Exclusive PDF Sample Copy of This Report @ https://www.coherentmarketinsights.com/insight/request-pdf/455 Market Dynamics: The recent past has witnessed a steady rise in incidence of zoonotic and infectious diseases in humans and animals as well, which lead to the increased research & developments for the innovation of new and effective recombinant vaccines for the prevention of diseases. Government has also taken an initiative to increase awareness regarding vaccination to prevent diseases in community. Manufacturing companies have also started some beneficial programs to provide vaccination free of cost to poor people, which creates a highly conducive environment for growth of the recombinant vaccines market in near future. National Immunization Program by Queensland Government in Australia and Indradhanush vaccination program in India works to provide vaccination among children throughout the nation. Various organizations such as World Health Organization, World Bank, and United Nations Children’s Funds has also taken and initiative to increase vaccination. The global recombinant vaccine market was valued at US$ 830.2 million in 2016 and is expected to witness a robust CAGR of 6.0% during the forecast period (2017 – 2025). Increase in the incidence of zoonotic diseases and emerging technologies expected to support the growth of recombinant vaccines market There is a constant increase in diseases caused by bacteria or virus such as swine flu, malaria, HPV and other diseases, which has raised the demand of vaccination and lead to the eradication of diseases such as polio, and tetanus in few countries. Whit the development in technology there is development in vaccines, which are more effective than conventional vaccines and does not lead to any side effect. These vaccines are easy to administer in the body orally, intramuscular or intradermal. In the U.S. there were around 212 million malaria cases and 429,000 deaths from malaria is reported in 2015. According to Centers for Disease Control and Prevention report 2017, in the U.S. there were around 49.9% of the children between the ages of 6 months to 17 years received an influenza vaccine. Top Key Players: Some major key players in the recombinant vaccines market include Merck & Co. Inc., Novartis AG, Protein Science Corporation, GlaxoSmithKline Plc., Green Cross Corporation, Bayer AG, Sanofi S A, Pfizer Inc., and Bharat Biotech. Detailed Segmentation: Global Recombinant Vaccines Market, By Product Type -
Global Recombinant Vaccines Market, By Disease Type -
Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/market-insight/recombinant-vaccine-market-455 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] 4/22/2019 Multiplexed Diagnostic Market : Focus on Screening, Monitoring, and Clinical DevelopmentRead NowMultiplexed diagnostics are used in investigation of biological samples, which are capable of completing a screening process with a single run. Multiplexed diagnostic assays are involved in the detection and diagnosis of different diseases and infections, which include cancers, autoimmune diseases, allergies, and cardiovascular diseases. Assays performed in multiplex diagnostics include high density multiplexed assays, medium density multiplexed assays, low density multiplexed assays, and next-generation sequencing assays. Early diagnosis can minimize the risk factors associated with chronic diseases/infection and helps in proper treatment management. Moreover, multiplexed diagnostic assays have advantages, such as time efficiency and highly precise accuracy, which can analyze defects and mutations in any functional biomolecules (DNA, RNA, and protein).
According to the Centers for Disease Control and Prevention (CDC), 2014, around 236,968 women are diagnosed with breast cancer. Increasing demand for early diagnosis of infection/diseases needs rapid multiplexed diagnostic tools, which is expected to boost the growth of the multiplexed diagnostic market. The global multiplexed diagnostic market is estimated to be valued at US$ 8,698.0 in 2017 and is expected to witness a CAGR of 7.9% during the forecast period (2017 – 2025). Request For Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/983 According to Cancer Research UK, around 20 cases of ovarian cancers are diagnosed every day and it is projected to increase by around 15% from 2014 to 2035. Furthermore, according to American Cancer Society (ACS), in 2017, approximately 53,670 people are expected to be diagnosed with pancreatic cancer in the U.S. Moreover, according to Cancer Research UK, approximately 3,072 new cases were diagnosed with acute myeloid leukemia (AML) in 2014. As per Cancer Research U.K, Acute Myeloid Leukemia (AML) accounts approximately 8 cases per day. Increasing incidence of multiple cancers is expected to increase the demand for precise multiplexed diagnostic tools, in turn fueling the market growth. Additionally, SpeeDx has received CE-IVD marking for its PlexPCR VHS Multiplex qPCR technology in October 2017. This diagnostic test is designed to detect and differentiate the four different genital and oral lesion viruses, which include herpes simplex virus types 1 and 2 (HSV-1 and -2), varicella-zoster virus (VZV), and Treponema pallidum (syphilis). Therefore, PlexPCR VHS Multiplex qPCR test is expected to provide early detection of infection and help in treatment decisions. Thus, advanced technology is expected to boost the growth of multiplexed diagnostic market during the forecast period. Introduction of advanced technology in multiplexed diagnostic tools, create a positive impact on patient and is expected to fuel the growth of the multiplexed diagnostic market Mercodia has launched the AKURIO Islet Hormone multiplex assay with the collaboration of Quansys Bioscience in October 2017. This assay is designed to assess four different hormones in pancreatic study, which include glucagon, insulin, C-peptide, and proinsulin. AKURIO Islet Hormone multiplex assay provides high data accuracy with reliable speed. Moreover, Bruker has received CE-IVD marking for its Fungiplex Candida diagnostic assay in October 2017. Fungiplex Candida is based on real-time PCR and gives results in 2-3 hours of blood, plasma or serum sample by cutting the edge of additional cultural steps. Thereby, establishment of rapid detection assay in fungal infection allows the development of effective treatment strategies for improved patient outcomes. The multiplexed diagnostic market is gaining significant traction due to the rising prevalence of autoimmune diseases. According to the Centers for Disease Control and Prevention (CDC), the prevalence of arthritis from 2013 to 2015, was estimated in 54 million U.S adults (22.7%) and by 2040, it is expected to be 78 million (26%) U.S adults age 18 years or older. The data represent the high prevalence of autoimmune diseases, indicating the need of advance diagnostic measures, which is expected to boost the growth of the multiplexed diagnostic market. Furthermore, introduction of technological advancement of multiplexed diagnostics is a major factor contributing to the market growth. For instance, IQuity launched RNA-based diagnostic test based on RT-PCR assay approved by U.S. Food and Drug Administration (FDA) in May 2017. RNA-based diagnostic test is used for detection of multiple sclerosis, which provides accuracy by 90%. However, the high cost of diagnostic procedures is a major restraining factor for the multiplexed diagnostic market. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/983 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:[email protected] Knee bracing devices are orthopedic tools that are mainly used for alignment, pain reduction and maintenance of structural and functional characteristics of the knee. Knee braces offer protection to the knees of patients suffering from osteoarthritis as well as are used in the treatment of meniscus injuries. Apart from these, knee braces can be used as safety devices while playing various sports such as running and soccer and are also used in injury rehabilitation. These are generally worn in case of knee pain. Knee braces are made from one or more combination of rigid and flexible materials like metal, plastic, moldable foam, synthetic rubber, padding or elastic material and straps. These knee braces are available is several sizes and have provisions for pressure adjustments. On the other hand, custom knee braces are designed in a way to perfectly fit the exact knee measurements.
Click the link to Get a Free Sample Copy of the Report: https://www.coherentmarketinsights.com/insight/request-sample/440 Increasing Knee injuries along with Osteoarthritis contributing to the boost of global knee braces market The knee braces consumption is mostly driven by patients suffering from osteoarthritis. According to WHO, over 20% of the world’s population aged over 60 that accounts for around 130 million people will suffer from osteoarthritis by the 2050. Additionally, the National Institute of Health reported 6,664,324 knee injuries in the U.S. from 1999 to 2008 and is expecting a significant in increase in this number by 2020. These estimates suggests a drastic boost for the global knee braces market during the forecast period. North America to hold largest share of the global knee braces market owing to increased osteoarthritis cases On the basis of regional segmentation, the knee braces market can be segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is the largest shareholder of the global market, followed by Europe. According to Centers for Disease Control and Prevention (CDC), around 30 million adults in the U.S. are affected with osteoarthritis in 2016 suggesting high consumption of knee braces for the treatment of this disease in the U.S. High incidence rates of osteoarthritis and meniscus injuries are responsible for driving the global knee braces market The prevalence and incidence rate of Osteoarthritis and meniscus injuries among the geriatric population are the primary reasons to drive the global knee braces market. The United Nations suggests that number of people aged over 60 years is projected to grow by 56%, accounting a rise from 901 million to 1.4 billion in the years 2015 to 2030. Moreover, according to the CDC data in 2015, 23.7 million adults in the U.S. have functional limitations in their regular movements due to doctor diagnosed arthritis suggesting strong probabilities of prevalence of osteoarthritis. Major Players The key players dominating the global knee braces market includes Alex Orthopedic Inc., Body Sport, Bell Horn, Cho-Pat, DJO Global, Medi-Dyne and Medline. These companies are holding a strong position in the global knee braces market due to high R&D investment costs and long term contract relationship with the customers. The global knee braces market can be segmented on the basis of product type, end user and geographical regions. On the basis of types of braces available, Rehabilitative braces: These are involves in providing stability to allow a limited movement while an injury is healing. Unloader braces: These braces are generally used by people suffering from arthritis to relieve the pain. Prophylactic braces: These are the protective braces generally worn to avoid knee injuries during sports. These braces are commonly used by athletes. Knee Sleeves: These are support devices that are used to provide compression around the knee joints are used for knee support and controlling pain and swelling around the knee area. Find the comprehensive research report here with a single click: https://www.coherentmarketinsights.com/ongoing-insight/knee-braces-market-440 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr. Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email: [email protected] Plant serves as an important source to produce cost-effective vaccine derivatives. Plant-based production of vaccine helps to reduce economic burden of infectious disease in emerging economies, owing to its large-scale production and cost-efficiency. Various clinical trials are focused on development of plant-based vaccines in therapeutic indications such as influenza, dengue, flu, and Ebola virus, which can be administered orally. Oral administration of these vaccines reduces the need of needles and syringes, which requires trained immunization staff and also reduces risk of Hospital Acquired Infections (HAIs).
The global plant-based vaccines market size is estimated to be valued at US$ 927.0 million in 2020 and is expected to witness a CAGR of 11.7% over the forecast period (2020–2026). Existing key players and new entrants in the plant-based vaccines market are focused on extensive clinical trial studies to develop plant-based vaccines for numerous therapeutic applications. For instance, Medicago Inc., a clinical-stage biotechnology company, which uses plant-based technologies to develop and produce novel vaccine and antibodies, is cultivating several tobacco plants (Nicotiana tabacum) at Durham's Research Triangle Park, North America, which will be used in testing and production of the flu vaccine. In March 2018, Medicago conducted phase III clinical trials to develop flu vaccine, which is expected to be launched in the market by 2020-21 influenza season. Furthermore, researchers require five to six weeks for production of plant-based vaccine, as compared to five to six month period to prepare the vaccine in chicken eggs, which is currently practiced by vaccine manufacturers. Request For Sample Copy: https://www.coherentmarketinsights.com/insight/request-sample/2004 Besides cost-efficiency, plant-based vaccines offer several benefits over conventional egg-based vaccine production, in terms of production time and enhancing immune system of the patient. For instance, Medicago's Quadrivalent Influenza Vaccine (QIV) is produced using novel Virus-Like Particle (VLP) technology, which offers new approach in vaccine development and production. In VLP technology, vaccine mimics the native structure of viruses, allowing them to easily get penetrated into patient’s immune system. Moreover, the QIV vaccine lacks core genetic material, rendering them to become non-infectious and unable to replicate. This makes plant-based vaccine safe and effective in inducing immune response of patient similar to natural infection without infecting the patient. Plant-based vaccine production offers better alternative over egg-based and cell-based vaccine production systems, by reducing lead time and increasing reliability and versatility. Furthermore, plant-based vaccine offers greater antigen specificity in disease treatment. Plant-based vaccine production enables manufacturers to create vaccine, which precisely matches the specific strain of influenza virus in patient’s circulation; as in case of flu infection, influenza virus mutates is constantly. For instance, according to Phase III clinical data study published by Medicago, in September 2017, Medicago's VLP vaccine during the phase II clinical trial stage showed higher antibody and Cell-Mediated Immunity (CMI) responses over comparator conventional vaccine. However, several challenges in manufacturing of plant-based vaccines is expected to restrain growth of the market. Plant-based vaccine production is a new technology and involves complex manufacturing and regulatory process. In egg-based production, whole flu viruses are injected into eggs, which then replicate and form the basis for the vaccine. In plant-based vaccine production method, manufacturers use only specific gene, which codes for protein called hemagglutinin, which is responsible for triggering immune system and encodes it into the tobacco plant leaves. In this context, companies need to pursue the U.S. Food and Drug Administration (FDA) approval to state that not only plant-based vaccine is safe and effective, but also the hemagglutinin or other proteins, which can be extracted from the plant leaves are according to the mentioned standard and that the manufacturing process yields a uniform and reliable product. Although various plant-based vaccines have been developed in various transgenic plants such as insulin in transgenic safflower, taliglucerase alfa in transgenic carrot, avian influenza vaccine in transgenic tobacco, and Ebola vaccine in transgenic tobacco, no plant-derived vaccine is yet approved for human consumption. Moreover, some of the challenges to develop effective vaccines from downstream processing to the implementation of the vaccines include, selection of antigen & plant expression host, uniformity of dosage, and manufacturing of plant vaccines according to Good Manufacturing Practice (GMP) procedures. Download the PDF brochure: https://www.coherentmarketinsights.com/insight/request-pdf/2004 About Coherent Market Insights: Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity. Contact Us: Mr.Shah Coherent Market Insights 1001 4th Ave, #3200 Seattle, WA 98154 Tel: +1-206-701-6702 Email:[email protected] |
Details
Global Industry Research Experienced Professional Freelancer with a demonstrated history of working in the information technology and services industry. Skilled in Front Office, Customer Service, Marketing, Microsoft Office, and Social Media. Strong media and communication professional with a Bachelor of Commerce - BCom focused in Computer and Information Sciences and Support Services from Pune University. Archives
July 2020
Categories |